Also found in: Dictionary, Medical.
Related to HUMIRA: Remicade, Enbrel
HUMIRAHuman Monoclonal Antibody in Rheumatoid Arthritis
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
United States-based Mylan has acquired an exclusive license to commercialise a biosimilar to Humira (adalimumab), developed by Fujifilm Kyowa Kirin Biologics, in Europe, it was reported yesterday.
This study was a 52-week open-label study to assess the efficacy and safety of Humira when increased to 80 mg every two weeks in which the primary efficacy evaluation
Humira generated $1.2 billion in third-quarter sales, up 50 percent from the-year ago period.
Mylan will pay royalties to AbbVie for licensing its Humira patents once its biosimilar product is launched.
Furthermore, there will be no change to the distribution and sales framework for HUMIRA (AbbVie is the marketing and manufacturing authorization holder for HUMIRA, while Eisai is responsible for distribution).
The global Humira Market is likely to exhibit steady growth over the forecast period, according to the latest report on Wise Guy Research (WGR).
The companies have developed several potentially promising medicines for a range of diseases, though so far none have convinced investors that they can attract the vast pool of patients that take medications like Humira.
Comments: Global HUMIRA sales were $19.9 billion, up 8% for the year.
announced that they have received approval for an additional indication of HUMIRA (generic name: adalimumab [recombinant], "HUMIRA"), a fully human anti-TNF-alpha monoclonal antibody, for the treatment of hidradenitis suppurativa (HS).